top of page
Search

SAS vs R in Clinical Trials: Which Should You Learn?

nehaeduvercity
8 hours ago
3 min read

By Neha Jain, Principal Consultant and SAS trainer · 17+ years training in SAS · 5,000+ learners trained · Updated 7 November 2026


"Should I learn SAS or R?" is one of the most common questions from people entering clinical programming. Both are used in clinical trials today, and the answer depends on where you want to work and how far into your career you are. This guide gives a balanced, practical answer.


The short answer

Learn SAS first if you want the widest range of clinical programming jobs today, then add R — the industry is moving towards programmers who can work in both. The CDISC standards, the analysis plans and the outputs are the same in either language.


SAS vs R in clinical trials compared: cost, FDA position, clinical toolkit, main strength and best fit

What the FDA actually accepts

The FDA does not require any specific software for statistical analyses. Its Statistical Software Clarifying Statement (May 2015) says the software used should be fully documented in the submission, including version and build. SAS became the default in the industry through convention, validated workflows and a large trained workforce — not because regulators demand it.


SAS vs R at a glance


SAS

R

Cost

Commercial licence

Free and open source

Regulatory acceptance

Accepted; long track record

Accepted; growing submission experience

Clinical toolkit

Base SAS, macros, PROC REPORT, ODS

pharmaverse packages such as admiral; table packages such as rtables and Tplyr

Strengths

Stability, validated in-house processes, support

Flexibility, graphics, rapid open-source innovation

Learning curve

Structured, consistent syntax

Very flexible; many ways to do one task

Job market

Required in most current CRO and pharma roles

Increasingly listed as required or preferred


The same task in SAS and R

Summarising age by treatment group in ADSL:

/* SAS */
proc means data=adam.adsl n mean std min max;
  class trt01a;
  var age;
run;
# R (dplyr)
library(dplyr)
adsl %>%
  group_by(TRT01A) %>%
  summarise(n = n(), mean = mean(AGE), sd = sd(AGE),
            min = min(AGE), max = max(AGE))

The logic is identical; only the syntax changes. That is why programmers with strong SAS foundations can add R relatively quickly.


Why R is growing in clinical trials

  • The pharmaverse. A cross-company collection of open-source packages, including admiral for ADaM derivations.

  • Industry pilots. Industry groups such as the R Consortium have run pilot submissions to the FDA using R.

  • Graduates. Many statistics and life-science graduates learn R at university.

  • Cost and flexibility. Open source lowers costs and makes modern graphics and apps easier.


Why SAS remains essential

  • Most existing clinical programming code, macros and standards are written in SAS.

  • Many CROs and sponsors still run SAS-based production and validation.

  • Programmers are often asked to double-program in both languages.

  • Long-term studies and legacy submissions keep SAS skills in demand.


Which should you learn first?

Your situation

Recommendation

Fresher targeting CRO or pharma jobs

SAS first, then R

Already a SAS programmer

Add R and the pharmaverse now

Statistics graduate who knows R

Add SAS for job-market access

Working in a team that is moving to R

Learn R deeply, keep SAS for legacy work


Frequently asked questions

Does the FDA require SAS? No. The FDA does not require any specific software, as long as the software used is documented in the submission.

Will R replace SAS in clinical trials? R is growing fast, but most teams are moving to a mixed world rather than a sudden switch. Knowing both is the safest career strategy.

Are CDISC standards different in R? No. SDTM, ADaM and define.xml are the same whichever language builds them.

How long does it take a SAS programmer to learn R? With strong SAS skills, many programmers become productive in R for clinical tasks within a few months of guided practice.


Learn SAS and R with Eduvercity

Eduvercity teaches both, live online with Neha Jain: Clinical SAS for the industry standard, and Clinical R Programming for SAS programmers moving to R with tidyverse and the pharmaverse.




About the author

Neha Jain is a Principal Consultant and Trainer at Eduvercity and works independently as a freelance SAS consultant and trainer. She has trained professionals in SAS for more than 17 years and has more than 20 years of experience as a global consultant across programming, data and project leadership, and has trained more than 5,000 students and professionals, as well as teams at companies worldwide. She teaches Base and Advanced SAS, Clinical SAS (CDISC SDTM, ADaM and TLFs), clinical R and Python to learners in India, the UAE, the UK, the USA and Canada, and advises teams moving clinical programming work from SAS to R. The views in this article are her own. More about Neha and Eduvercity.

 
 
 

Comments


Frequently Asked Questions

Q: Are classes live or recorded?
A: Classes are live and online, with the trainer teaching each session.

​

Q: Can I join from outside India?
A: Yes. Batches are timed for learners in India, the UAE, the UK, the USA and Canada.

​

Q: Do I need a programming background?
A: Not for Base SAS, Clinical SAS or the beginner R and Python courses.

​

Q: Do I get a certificate?
A: Yes, an Eduvercity course-completion certificate. For SAS certification, we train you for the SAS exams, clear your doubts and guide your preparation; you book and take the exam directly with SAS.

​

Q: Is Eduvercity an official SAS or R partner?
A: No. Eduvercity is an independent training provider that teaches SAS and R tools and concepts.

​

Q: How do I enrol and pay?
A: WhatsApp us on +91 80509 22145 for fees and the next batch. Payment is by UPI or bank transfer.

+91 80509 22145

  • Facebook
  • YouTube

© 2026 Eduvercity. All rights reserved

SAS is a registered trademark of SAS Institute Inc. R is a project of the R Foundation. Eduvercity is an independent training provider and is not affiliated with or endorsed by either.

bottom of page